Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 9/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.74 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.74 |
| ▸ | RAB9A | P51151 | 1/20 | 0.74 |
| ▸ | POLB | P06746 | 1/20 | 0.62 |
| ▸ | BRD4 | O60885 | 1/20 | 0.57 |
| ▸ | BRD2 | P25440 | 1/20 | 0.57 |
| ▸ | BRD3 | Q15059 | 1/20 | 0.57 |
| ▸ | BRDT | Q58F21 | 1/20 | 0.57 |
| ▸ | CA1 | P00915 | 2/20 | 0.51 |
| ▸ | CA9 | Q16790 | 2/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.51 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3192482 | 0.78 | KDM4E (0.84) | GAAKDM4ESMN1; SMN2ALDH1A1RAB9A | |
| SCHEMBL4470797 | 0.74 | GAA (0.59) | GAAKDM4ESMN1; SMN2ALDH1A1RAB9A | |
| SCHEMBL1617368 | 0.71 | BRD4 (0.70) | GAAKDM4ESMN1; SMN2ALDH1A1RAB9A | |
| SCHEMBL13701754 | 0.70 | BRD4 (0.73) | GAAKDM4ESMN1; SMN2ALDH1A1RAB9A | |
| SCHEMBL13702152 | 0.70 | BRD4 (0.73) | GAAKDM4ESMN1; SMN2ALDH1A1RAB9A | |
| SCHEMBL6199097 | 0.70 | BRD4 (0.68) | GAAKDM4ESMN1; SMN2ALDH1A1RAB9A | |
| SCHEMBL3522227 | 0.69 | GAA (0.53) | GAAKDM4ESMN1; SMN2ALDH1A1POLB | |
| SCHEMBL11324370 | 0.69 | BRD4 (0.67) | GAAKDM4ESMN1; SMN2ALDH1A1RAB9A | |
| SCHEMBL12734333 | 0.69 | BRD4 (0.71) | GAAKDM4ESMN1; SMN2ALDH1A1RAB9A | |
| SCHEMBL11316074 | 0.68 | BRD4 (0.70) | GAAKDM4ESMN1; SMN2ALDH1A1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040058964-A1 | Substituted pyridinones | PHARMACIA LLC | 2004-03-25 | — | — | US | claimed |
| US-7629363-B2 | antiinflammatory agent for treating asthma and chronic pulmonary inflammatory disease | PFIZER INC (US) | 2009-12-08 | — | — | US | disclosed |
| US-7067540-B2 | Substituted pyridinones | PHARMACIA CORPORATION (US) | 2006-06-27 | — | — | US | disclosed |
| US-20050176775-A1 | Substituted pyridinones | PHARMACIA CORPORATION | 2005-08-11 | — | — | US | disclosed |
| US-20040058964-A1 | Substituted pyridinones | PHARMACIA LLC | 2004-03-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040058964-A1 | Substituted pyridinones | MAPK1, MAPK6, MAPK7 | GAA 2281/4885KDM4E 3869/4885SMN1; SMN2 1433/4885 |
| US-20050176775-A1 | Substituted pyridinones | MAPK1, MAPK6, MAP3K6 | GAA 2368/4885KDM4E 3921/4885SMN1; SMN2 1419/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.